Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism
Gilles Maussion(Douglas Mental Health University Institute), Michel Simonneau(Inserm), Ulla Milbreta(Inserm), Anne Philippi(Genopole (France)), Philip Gorwood(Inserm), Yann Loe-Mie(Inserm), Alain Chédotal(Centre National de la Recherche Scientifique), Karine Fontaine(Genopole (France)), Aude-Marie Lepagnol-Bestel(Centre National de Recherche en Génomique Humaine), J. Renaud(Institut de la Vision), Jérôme Carayol(Nestlé (Switzerland)), Jörg Hager(Nestlé (Switzerland)), F. Rousseau(Genopole (France)), Nicolás Ramoz(Inserm), Jean‐Marie Moalic(Inserm), Frédéric Torès(Genopole (France))
Cited by 84
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k